Japan News
-
Chugai starts Ph III trial of Actemra for COVID-19 pneumonia
Japan | News | 0 Comment | 10 Apr, 2020
Japan based Chugai Pharmaceutical Co., Ltd. has announced that it is working to start a Phase III clinical trial in Japa...Read more
-
Jolly Good, NCCBTR collaborate for VR Therapeutics
Japan | News | 0 Comment | 06 Apr, 2020
Japanese startup Jolly Good Inc. and the National Center for Cognitive Behavior Therapy and Research (NCCBTR) announced ...Read more
-
SanBio, Ocumension enter into biz alliance for treating eye diseases
Japan | News | 0 Comment | 07 Apr, 2020
Japan based SanBio and Hong Kong based Ocumension have entered into a business alliance for the research, development an...Read more
-
Genesis Healthcare unveils new detection test for COVID-19
Japan | News | 0 Comment | 03 Apr, 2020
Genesis Healthcare Co., Japan's leading genetic testing and research company, today announced the launch of a real-time ...Read more
-
Japan Coronavirus COVID-19 (2019-nCoV) Pandemic Dashboard : Daily Confirmed Cases
Japan | News | By Ankit Kankar | 0 Comment | 03 Apr, 2020
Daily New Confirmed Cases : Japan ...Read more
-
Japan’s MEXT awarded the A-PRAS certificate to Impact Science
Japan | News | 0 Comment | 02 Apr, 2020
Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT) awarded Impact Science with the Accr...Read more
-
Daiichi Sankyo, Ultragenyx partner for gene therapy manufacturing technology
Japan | News | 0 Comment | 01 Apr, 2020
Japan based Daiichi Sankyo Company, Limited has announced that it has entered into a strategic partnership with US based...Read more
-
GHIT Fund announces new investment of 3.29 B Yen
Japan | News | 0 Comment | 01 Apr, 2020
Japan based Global Health Innovative Technology (GHIT) Fund has announced a total of 3.29 billion yen (US$30 m...Read more
-
Hitachi to establish Lumada Data Science lab
Japan | News | 0 Comment | 31 Mar, 2020
Japan based Hitachi, Ltd. on 30 March 2020 announced that on April 1, it will establish the "Lumada(1) Data Science Lab....Read more
-
Daiichi Sankyo ends influenza vaccine sales deal with Kitasato
Japan | News | 0 Comment | 30 Mar, 2020
Japan based Daiichi Sankyo Company, Limited and Kitasato Pharmaceutical Industry Co., Ltd. have announced the terminatio...Read more
-
CG Oncology inks agreement with Kissei Pharma for $40M
Japan | News | 0 Comment | 27 Mar, 2020
US based CG Oncology, Inc. has announced an exclusive license, development and commercialization agreement with Japanese...Read more
-
Daiichi Sankyo receives approval for new breast cancer drug
Japan | News | 0 Comment | 26 Mar, 2020
Japan based Daiichi Sankyo Company, Limited has announced the approval of ENHERTU® (trastuzumab deruxtecan), a HER2 ...Read more
-
CytomX, Astellas to find cure for cancer
Japan | News | 0 Comment | 25 Mar, 2020
US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...Read more
-
Diagnostic biomarker for acute adult T-cell cancers discovered
Japan | News | 0 Comment | 23 Mar, 2020
A study jointly conducted by Dean and Professor Takuya Fukushima, M.D., Ph.D., Graduate School of Health Sciences, Unive...Read more
-
Eisai to launch digital tool to assess brain health
Japan | News | 0 Comment | 24 Mar, 2020
Japan based company Eisai will launch "NouKNOWTM" (pronounced "NOH-NOH"), a new digital tool (non-medical device) for se...Read more
-
Gifu University, Astellas to create new treatments for bacterial infections
Japan | News | 0 Comment | 23 Mar, 2020
Japan based Gifu University and Astellas Pharma Inc. have announced that the parties have established, inside Gifu Unive...Read more
-
Eppendorf acquires centrifuge biz of Koki Holdings
Japan | News | 0 Comment | 20 Mar, 2020
Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centri...Read more
-
Japan approves Novartis' SMA drug
Japan | News | 0 Comment | 19 Mar, 2020
Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...Read more
